Australian Institute of Health and Welfare. What do Australians die from? In: Life expectancy and deaths report July 2024. Archived: https://pp.aihw.gov.au/reports/life-expectancy-deaths/what-do-australians-die-from/contents/about (2025).
Xu X, Islam SMS, Schlaich M, Jennings G, Schutte AE. The contribution of raised blood pressure to all-cause and cardiovascular deaths and disability-adjusted life-years (DALYs) in Australia: Analysis of global burden of disease study from 1990 to 2019. PLoS ONE. 2024;19:e0297229.
Atkins ER, Nguyen LH, Chatterton ML, Schlaich M, Schutte AE, Rodgers A. The cost of treating hypertension in Australia, 2012–22: an economic analysis. Medical J Aust. 2024;221:612–6.
Australian Bureau of Statistics. National Health Survey: First Results, 2021–22. Released 6 December 2022. Archived: https://www.abs.gov.au/statistics/health/health-conditions-and-risks/national-health-survey/latest-release (2025).
Wang X, Shaw JE, Yu J, Jennings G, Stavreski B, Magliano D, et al. Prevalence, awareness, treatment, and control rates of hypertension in the general population of Australia: a systematic review and meta-analysis. J Hypertens. 2024;43:185–90.
Weintraub WS, Daniels SR, Burke LE, Franklin BA, Goff DC Jr, Hayman LL, et al. Value of primordial and primary prevention for cardiovascular disease. Circulation. 2011;124:967–90.
Schutte AE, Bennett B, Chow CK, Cloud GC, Doyle K, Girdis Z, et al. National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030. Med J Aust. 2024;221:126–34.
Jeemon P, Séverin T, Amodeo C, Balabanova D, Campbell NRC, Gaita D, et al. World Heart Federation Roadmap for Hypertension – A 2021 Update. Glob Heart. 2021;16:63.
Park C, Wang G, Durthaler JM, Fang J. Cost-effectiveness analyses of antihypertensive medicines: a systematic review. Am J Prev Med. 2017;53:S131–42.
Pickersgill SJ, Msemburi WT, Cobb L, Ide N, Moran AE, Su Y, et al. Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes. Nature Med. 2022;28:1693–9.
Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–51.
Paige E, Banks E, Agostino J, et al. The relationship of socioeconomic factors to the use of preventative cardiovascular disease medications: a prospective Australian cohort study. Preventive Med. 2022;154:106884.
Australian Bureau of Statistics. National Health Survey: Information on health behaviours cp, and risk factors in Australia. Archived: https://www.abs.gov.au/statistics/health/health-conditions-and-risks/national-health-survey/2022#data-downloads (2025).
Musonge-Effoe JE, Alema-Mensah E, Effoe VS, Akinnawo F, Caplan L. The association between health care coverage and prevalence of cardiovascular diseases and diabetes over a 10-year period. Preventive Med. 2020;132:105983.
Wilkins RV-TE, Botha F. The Household, Income and Labour Dynamics in Australia Survey: Selected Findings from Waves 1 to 21. Melbourne Institute: Applied Economic & Social Research, University of Melbourne; 2024. Archived at: https://melbourneinstitute.unimelb.edu.au/__data/assets/pdf_file/0008/4841909/HILDA_Statistical_Report_2023.pdf (2025).
Summerfield, M, Garrard, B, Nesa, M, Kamath, R, Macalalad, N, Watson, N, et al. HILDA User Manual – Release 23. Melbourne Institute: Applied Economic and Social Research, University of Melbourne; 2024. Archived: https://melbourneinstitute.unimelb.edu.au/hilda/publications/hilda-statistical-reports (2024).
Australian Government Department of Health and Aged Care. PBS/RPBS Under Co-payment Prescriptions Data 2023-24. Archived: https://www.pbs.gov.au/info/statistics/under-co-payment/ucp-data-report#:~:text=From%201%20January%202024%20the,patients%20make%20toward%20their%20medicines (2025).
Watson N, Wooden MP. The HILDA survey: a case study in the design and development of a successful household panel survey. Longit Life Course Stud. 2012;3:369–81.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–82.
Rijnhart JJM, Twisk JWR, Chinapaw MJM, de Boer MR, Heymans MW. Comparison of methods for the analysis of relatively simple mediation models. Contemporary Clin Trials Commun. 2017;7:130–5.
Nolde JM, Streets F, Meyer D, Chen WS, Wei J, Wickramasinghe N, et al. Trends in blood pressure changes and hypertension prevalence in Australian adults before and during the COVID-19 pandemic. J Clin Hypertens. 2024;26:145–54.
Carnagarin R, Nolde JM, Yang J, Marques FZ, Picone DS, Lambert GW, et al. Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10 046 participants of the May Measurement Month campaigns. J Hypertens. 2023;41:632–7.
Australian Institute of Health and Welfare. Heart, stroke and vascular disease: Australian facts, 2024. Archived: https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/risk-factors/high-blood-pressure (2025).
Adams A, Kluender R, Mahoney N, Wang J, Wong F, Yin W. The Impact of Financial Assistance Programs on Health Care Utilization: Evidence from Kaiser Permanente. Am Econ Rev Insights. 2022;4:389–407.
Saxby K, Zhang Y. Bulk-billing rates and out-of-pocket costs for general practitioner services in Australia, 2022, by SA3 region: analysis of Medicare claims data. Med J Aust. 2024;222:144–8.
Khatib R, Schwalm JD, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies. PLOS ONE. 2014;9:e84238.